We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A case of Olmsted syndrome with dramatic response to erlotinib.
- Authors
Oldham, Jaimie; O'Toole, Edel
- Abstract
A 63-year-old man with Olmsted syndrome, a rare genetic condition, experienced intense pain and severe impact on his quality of life. Genetic testing confirmed a TRPV3 mutation, and treatment with erlotinib led to a dramatic improvement in pain within 24 hours. The patient's condition significantly improved over three months with erlotinib, highlighting its effectiveness in treating Olmsted syndrome. This case adds to the evidence supporting erlotinib as a potential treatment option for this condition.
- Subjects
TRP channels; EPIDERMAL growth factor receptors; DRUG efficacy; GAIN-of-function mutations; PROTEIN-tyrosine kinase inhibitors
- Publication
Clinical & Experimental Dermatology, 2024, Vol 49, Issue 12, p1755
- ISSN
0307-6938
- Publication type
Academic Journal
- DOI
10.1093/ced/llae193